Cargando…
c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
BACKGROUND: c-Met is widely known as a poor prognostic factor in various human malignancies. Previous studies have suggested the involvement of c-Met and/or its ligand, hepatocyte growth factor (HGF), in esophageal squamous cell carcinoma (ESCC), but the correlation between c-Met status and clinical...
Autores principales: | Ozawa, Yohei, Nakamura, Yasuhiro, Fujishima, Fumiyoshi, Felizola, Saulo JA, Takeda, Kenichiro, Okamoto, Hiroshi, Ito, Ken, Ishida, Hirotaka, Konno, Takuro, Kamei, Takashi, Miyata, Go, Ohuchi, Noriaki, Sasano, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453225/ https://www.ncbi.nlm.nih.gov/pubmed/26036285 http://dx.doi.org/10.1186/s12885-015-1450-3 |
Ejemplares similares
-
Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013) -
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
por: Okamoto, Hiroshi, et al.
Publicado: (2015) -
Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus
por: Ishida, Hirotaka, et al.
Publicado: (2015) -
GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy
por: Ueki, Shunsuke, et al.
Publicado: (2020) -
A comparative analysis of clinicopathological factors between esophageal small cell and basaloid squamous cell carcinoma
por: Ishida, Hirotaka, et al.
Publicado: (2019)